1
/
of
0
FDA Drug Approval, N204447, TRINTELLIX
FDA Drug Approval, N204447, TRINTELLIX
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 204447
Company: TAKEDA PHARMS USA
Drug Name: TRINTELLIX
Active Ingredients: VORTIOXETINE HYDROBROMIDE
Strength: EQ 20MG BASE
Dosage Form/Route: TABLET;ORAL
Action Date: 09/30/2013
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Company: TAKEDA PHARMS USA
Drug Name: TRINTELLIX
Active Ingredients: VORTIOXETINE HYDROBROMIDE
Strength: EQ 20MG BASE
Dosage Form/Route: TABLET;ORAL
Action Date: 09/30/2013
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details